Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-3397.61%
↓ 426% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
-645.53%
Historical baseline
PeriodValueYoY Change
2024-3397.61%-1987.1%
2023-162.79%+48.0%
2022-312.79%-
20210.00%-
20200.00%-
20190.00%-